326 related articles for article (PubMed ID: 12404946)
1. [Hormone replacement therapy and breast cancer].
Mueck AO
Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
[No Abstract] [Full Text] [Related]
2. Estrogen replacement therapy and breast cancer.
Maguire PJ
J Reprod Med; 1993 Mar; 38(3):183-5. PubMed ID: 8487233
[TBL] [Abstract][Full Text] [Related]
3. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
Brettes JP; Mathelin C
Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
[No Abstract] [Full Text] [Related]
4. Hormone replacement therapy and breast cancer: an overview.
Theriault RL
Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
[No Abstract] [Full Text] [Related]
5. [Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].
Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Oct; 27(1 Suppl):12-6. PubMed ID: 9864684
[No Abstract] [Full Text] [Related]
6. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
7. [Hormone substitution therapy in menopause and risk of breast cancer].
Colin C
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy and breast cancer--any news?].
Holli K
Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
[No Abstract] [Full Text] [Related]
9. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect modification between estrogen metabolism genotypes and combined hormone replacement therapy in postmenopausal breast cancer risk.
Rebbeck TR; Troxel AB; Shatalova EG; Blanchard R; Norman S; Bunin G; Demichele A; Schinnar R; Berlin JA; Strom BL
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1318-20. PubMed ID: 17548708
[No Abstract] [Full Text] [Related]
11. Menopausal hormone therapy in BRCA1 mutation carriers: uncertainty and caution.
Chlebowski RT; Prentice RL
J Natl Cancer Inst; 2008 Oct; 100(19):1341-3. PubMed ID: 18812547
[No Abstract] [Full Text] [Related]
12. Breast cancer and hormone-replacement therapy.
Bluming AZ
N Engl J Med; 1995 Nov; 333(20):1357; author reply 1357-8. PubMed ID: 7566037
[No Abstract] [Full Text] [Related]
13. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?
Soerjomataram I; Coebergh JW; Louwman MW; Visser O; van Leeuwen FE
J Clin Oncol; 2007 Nov; 25(31):5038-9; author reply 5039-40. PubMed ID: 17971608
[No Abstract] [Full Text] [Related]
14. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
15. Hormone replacement therapy and breast cancer.
Ramsey-Stewart G
Med J Aust; 1993 Mar; 158(6):436. PubMed ID: 8479368
[No Abstract] [Full Text] [Related]
16. [Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
Punnonen R
Duodecim; 1996; 112(12):1110-5. PubMed ID: 10593013
[No Abstract] [Full Text] [Related]
17. [The taking of sex hormone preparations and the risk of developing breast cancer].
Levshin VF
Vopr Onkol; 1992; 38(8):899-909. PubMed ID: 1300798
[No Abstract] [Full Text] [Related]
18. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
[No Abstract] [Full Text] [Related]
19. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
20. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
Odlind V
Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
